UK cancer deaths drop to a historic low amid screening and vaccines

New data from Cancer Research UK show UK cancer deaths between 2022–2024 fell to a record low (about 247 per 100,000), down from a 1989 peak of 355 per 100,000, a ~29% decline. The drop reflects sustained investment in research, prevention, and treatments, with major gains in stomach, lung, ovarian, breast, and prostate cancers. Cervical cancer deaths have fallen 75% since the 1970s largely due to national screening and the HPV vaccine. Screening programs (cervical, breast, colorectal, PSA testing) and advances like targeted therapies and immunotherapy have improved early detection and survival. However, total deaths may still rise as the population ages. Some cancers are increasing (skin, liver, kidney) and others remain stable, but experts forecast further decreases with continued investment and screening expansion.